(1 - 40 from 55
)
Gespräch mit Oliver Mühlemann, Leiter des Nationalen SWITCH.chtube.switch.ch › switchcast › unibe.ch › events
tube.switch.ch
Gespräch mit Oliver Mühlemann, Leiter des Nationalen Forschungsschwerpunkts «RNA & Disease». Wissenschaftsmagazin UniPress – das Gespräch.
Editorial Oliver Mühlemann - The Messenger No. 13nccr-rna-and-disease.ch › news › newsletter › oliver-muehlemann-editorial...
nccr-rna-and-disease.ch
It is now 6 months since our last newsletter and as we are all slowly recovering from the coronavirus pandemic and the associated temporary shutdown of our labs ...
Phase 2 Contract Signed: Outcome & Outlook - NCCR RNA & Diseasenccr-rna-and-disease.ch › news › newsletter › oliver-muehlemann-message...
nccr-rna-and-disease.ch
Oliver Mühlemann signs the contract for Phase 2 of the NCCR RNA & Disease. It is now almost 2 years ago when I could announce in “The Messenger” the ...
New defence mechanism against viruses discovered | ETH Zurich
ethz.ch
Helenius and Voinnet's groups have published their two research papers on human cells and plants in the latest edition of the journal Cell Host & Microbe – the former in collaboration with the group of Oliver Mühlemann, a professor at the University of Bern, who has dealt intensively with the NMD system in ...
sorted by relevance / date